PMV Pharmaceuticals Inc. (PMVP)

AI Score

Unlock

0.96

-0.04 (-4.00%)

At close: Apr 07, 2025, 3:59 PM

0.95

-0.56%

After-hours: Apr 07, 2025, 07:06 PM EDT

PMV Pharmaceuticals Income Statement

Chart Mode

Financials in USD. Fiscal year is January - December.

Chart Mode

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q1 2019
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Mar 31, 2019
Cash & Equivalents	40.88M	48.81M	49.35M	48.48M	38.53M	52.06M	68.21M	142.94M	108.3M	99.85M	87.09M	115.77M	172.47M	176.64M	189.42M	208.78M	361.42M	373.15M	148.02M	-101.49M	73.28M	-61.91M
Short-Term Investments	128.58M	134.03M	164.39M	150.28M	165.35M	149.86M	118.88M	86.49M	132.76M	159.01M	190.34M	167.22M	124.7M	131.01M	128.93M	122.71M	n/a	n/a	8.09M	202.97M	28.21M	123.81M
Long-Term Investments	13.84M	15.1M	n/a	15.12M	25.5M	36.18M	31.76M	n/a	2.5M	n/a	n/a	11.77M	16.91M	18.6M	20.61M	16.89M	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	235K	242K	182K	182K	190K	180K	181K	314K	313K	307K	308K	221K	221K	218K	201K	1.02M	201K	201K	1.68M	-101.49M	201K	-61.91M
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	6.2M	6.78M	5.87M	822K	4.35M	3.38M	3.33M	3.84M	5.95M	822K	822K	822K	822K	822K	822K	3.46M	3.34M	522K	n/a	n/a	n/a	n/a
Total Current Assets	175.66M	189.62M	218.79M	202.46M	207.41M	205.3M	190.41M	233.28M	247.01M	265.18M	281.87M	288.04M	301.29M	313.56M	323.08M	334.95M	364.76M	373.67M	156.76M	101.49M	102.09M	61.91M
Property-Plant & Equipment	1.55M	18.54M	18.57M	19.11M	19.05M	19.37M	19.86M	20.37M	20.49M	19.5M	18.39M	14.97M	13.15M	11.8M	12.02M	1.52M	569K	573K	609K	n/a	739K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	15.63M	33.88M	18.75M	34.42M	44.74M	55.73M	51.8M	20.68M	23.3M	19.81M	18.7M	26.97M	30.28M	30.62M	32.83M	19.44M	770K	774K	2.29M	-101.49M	940K	-61.91M
Total Assets	191.29M	223.5M	237.54M	236.88M	252.15M	261.03M	242.22M	253.96M	270.31M	284.98M	300.56M	315.01M	331.57M	344.18M	355.91M	354.39M	365.53M	374.45M	159.04M	n/a	103.03M	n/a
Account Payables	6.58M	2.06M	4.53M	859K	3.24M	1.68M	3.49M	1.77M	3M	4.83M	3.35M	4.86M	3.19M	1.28M	2.37M	1.25M	1.61M	548K	2.15M	n/a	2.84M	n/a
Deferred Revenue	n/a	n/a	-1.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	403K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	1.15M	n/a	852K	n/a	18K	281K	n/a	394K	383K	258K	403K	545K	677K	666K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	5M	10.26M	1.85M	n/a	4.59M	n/a	5.21M	6.41M	n/a	3.08M	4.76M	4.55M	4.43M	3.31M	1.62M	1.4M	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	14.37M	13.56M	11.38M	12.06M	14.03M	10.72M	11.45M	10.59M	10.83M	11.66M	11.38M	11.69M	12.22M	8.56M	7.5M	5.8M	6.41M	5.48M	5.05M	n/a	4.52M	n/a
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	94K	n/a	168.98M	n/a
Total Long-Term Liabilities	838K	12.02M	11.84M	12.14M	12.43M	12.7M	12.96M	13.2M	13.45M	12.13M	12.21M	11.48M	10.79M	10.67M	10.56M	302K	n/a	n/a	94K	n/a	168.98M	n/a
Total Liabilities	15.21M	25.59M	23.22M	24.2M	26.46M	23.41M	24.41M	23.79M	24.28M	23.79M	23.59M	23.16M	23.01M	19.23M	18.06M	6.1M	6.41M	5.48M	5.15M	n/a	173.51M	n/a
Total Debt	1.19M	13.27M	12.99M	13.02M	13.29M	12.7M	12.98M	13.48M	13.98M	12.53M	12.59M	11.74M	11.19M	11.21M	11.24M	968K	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-368.71M	-345.71M	-326.49M	-325.27M	-310M	-294.25M	-277.61M	-260.17M	-241.04M	-221.7M	-203.47M	-186.16M	-167.73M	-149.37M	-134.36M	-121.48M	-109.88M	-99.43M	-90.66M	n/a	-75.44M	n/a
Comprehensive Income	139K	410K	-185K	-129K	224K	-355K	-328K	-116K	-445K	-1.02M	-1.02M	-666K	-78K	14K	7K	-13K	n/a	-1.5M	5K	-70.47M	-3K	-46.14M
Shareholders Equity	176.08M	197.91M	214.31M	212.68M	225.69M	237.61M	217.81M	230.17M	246.03M	261.19M	276.97M	291.84M	308.56M	324.95M	337.85M	348.3M	359.12M	368.97M	153.9M	98.46M	-70.47M	61.09M
Total Investments	142.42M	149.13M	164.39M	165.41M	190.86M	149.86M	118.88M	86.49M	135.25M	159.01M	190.34M	178.99M	141.61M	149.61M	149.54M	139.6M	n/a	n/a	8.09M	202.97M	28.21M	123.81M